Evaluation of Drug Utilization Patterns Based on World Health Organization Drug use Indicators at Outpatients Clinics

Kayamkani Abedulla Khan1,*, Saif Mohammed Al-ghamdi1, Nawaf Mohammed Al-ghamdi1, Abdullah Radwan Al-saqqa1, Hashim Khalid Halawani1, Aejaz A. Khan2,  S. M. Shakeel Iqubal2, Muazzam Sheriff Maqbul3, Noorulla Khan Mayana4

1Department of Clinical Pharmacy & Pharmacology, Ibn Sina National College For Medical Studies, Jeddah, Kingdom of Saudi Arabia

2Department of General Sciences, Ibn Sina National College For Medical Studies, Jeddah, Kingdom of Saudi Arabia

3Faculty of Microbiology and Immunology, Ibn Sina National College of Medical Sciences, Al Mahjar Street: 31906, Jeddah 21418, Kingdom of Saudi Arabia

4Department of Emergency Medicine, Yashoda Hospitals, Malakpet, Hyderabad, India

Adv. Mater. Lett., 2020, 11 (3), 20031489 (1-4)

DOI: 10.5185/amlett.2020.031489

Publication Date (Web): Feb 26, 2020

E-mail: abidulla.k@gmail.com


Irrational drug prescribing is considered one of the prime challenges for the healthcare sectors worldwide, leading to baneful outcomes in patients. The World Health Organization (WHO) drug use indicators include prescribing indicators, patient care indicators and facility indicators and prescribing indicators measure the performance of health care providers in several key dimensions related to the appropriate use of drugs. Patient care indicators are used to understand the way drugs are used. To evaluate the trends and issues related to prescription, patient care and facility at outpatient clinics in Jeddah and to contrast that to the WHO drug use indicators. A Cross-sectional study conducted between January to April 2019. A total of 153 prescriptions were collected from outpatient clinics of private and governmental hospitals were analyzed according to WHO guidelines. The statistical calculations were performed using Microsoft excel software. The results illustrate that the average number of drugs per prescription was 4.56 and the percentage of encounter with antibiotics was 8.4. A comparatively encouraging observations were observed during generic prescribing as it was observed to be 54.2%, the percentage of encounters with injection was 7.8 and the percentage of drugs prescribed from essential drug list (EDL) or formulary was 92%. The prescribed drugs average number per encounter was greater than what was considered ideal according to WHO standards; the other issue found was a lower percentage of generic prescribing compared to WHO ideal value, the rest of prescribing indicators including the prescribing from the essential drug list was almost similar to the ideal value recommended by the WHO (100%).


World Health Organization indicator, prescribing indicators, patient care indicators, and healthcare facility indicators.

Previous issues

Celebrating 10th Years of Diamond Open Access Publishing in Advanced Materials  

Cerebral Oxygenation Studies Through Near Infrared Spectroscopy: A Review

Analysis of Fine Sulfoaluminate Cement by Strength and Thermogravimetric Analysis

Characterization of the Interfacial Surface Energy for Composite Electrical Conduction Measurements using Two Full Range Percolation Threshold Models

Quantitative Detect of Fatigue of Membrane of Erythrocyte in Uniform Shear Field

Ecofriendly-developed Polyacrylic Acid-coated Magnetic Nanoparticles as Catalysts in Photo-fenton Processes

Evaluation of Drug Interactions with Medications Prescribed to Ambulatory Patients with Metabolic Syndrome in Urban Area

Fiber-reinforced Cementitious Composite: Sensitivity Analysis and Parameter Identification 

Evaluation of Drug Utilization Patterns Based on World Health Organization Drug use Indicators at Outpatients Clinics

Are Quantitatively Micro-machined Scaffolds Effective for Cell Technology?

Synthesis and Characterization of Gold Nanoparticles from Lobelia Nicotianifolia Leaf Extract and its Biological Activities

Advanced Oxidations of Tartrazine Azo-dye

Antifungal Activity of Salvia jordanii Against the Oral Thrush Caused by the Cosmopolitan Yeast Candida albicans among Elderly Diabetic Type 2 patients

Upcoming Congress

Knowledge Experience at Sea TM